{"id":"W4403734664","doi":"10.1186/s12885-024-12841-2","title":"Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC","year":2024,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Pemetrexed; Carboplatin; Canakinumab; Gemcitabine; Internal medicine; Cisplatin; Oncology; Chemotherapy; non-small cell lung cancer (NSCLC); Lung cancer; Gastroenterology; Pharmacology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001102719,0.0005595586,0.001528955,0.0002685415,0.0003085416,0.000641336,0.0004683426,0.0005393,0.0006596036],"category_scores_gemma":[0.001344557,0.0002910974,0.0007902078,0.0003640625,0.0004384301,0.0004869558,0.0002645971,0.001157072,0.000181255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009170623,"about_ca_system_score_gemma":0.001159918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008170838,"about_ca_topic_score_gemma":0.002365861,"domain_scores_codex":[0.9995517,0.0001849373,0.00004552661,0.0001011006,0.00006013537,0.00005656489],"domain_scores_gemma":[0.9994034,0.000132495,0.0001183813,0.00005150554,0.00004277079,0.0002514309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4736044,0.02670793,0.166385,0.00166003,0.003223482,0.001799362,0.00105352,0.006121403,0.06723205,0.0002132062,0.003305402,0.2486943],"study_design_scores_gemma":[0.1491582,0.6171871,0.203375,0.0001073876,0.002493719,0.002950581,0.0002718024,0.005394322,0.0119401,0.000322546,0.006726409,0.0000729679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980142,0.001262125,0.00007219568,0.00009803295,0.00002631041,0.0001346632,0.00009603272,0.000010323,0.0002860971],"genre_scores_gemma":[0.9986684,0.0004823189,0.0001947502,0.0001661321,0.00004324392,0.00007974699,0.0002287564,0.00000312139,0.0001335617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001528955,"threshold_uncertainty_score":0.006653786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01733966717411547,"score_gpt":0.285425437066902,"score_spread":0.2680857698927866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}